Neutrophil extracellular traps

Neutrophil extracellular traps (NETs) are web-like structures composed of neutrophil chromatin and granule proteins that are released by activated neutrophils in response to various stimuli. These structures play a crucial role in the immune response by trapping and killing pathogens, such as bacteria, fungi, and viruses. NETs are also involved in the pathogenesis of various diseases, including autoimmune disorders, cancer, and thrombosis.
The formation of NETs, known as NETosis, is a complex process that involves the activation of neutrophils and the release of their nuclear contents into the extracellular space. This process is triggered by various stimuli, including microbial products, cytokines, and oxidative stress. Once released, NETs can ensnare and kill pathogens through a combination of histones, DNA, and antimicrobial proteins.
While NETs play a crucial role in host defense, dysregulated NET formation has been implicated in the pathogenesis of several diseases. For example, excessive NET formation has been linked to the development of autoimmune disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Additionally, NETs have been shown to promote thrombosis by activating platelets and the coagulation cascade.
Research into the role of NETs in disease pathogenesis is ongoing, with potential implications for the development of novel therapeutic strategies targeting NET formation and function. Understanding the complex interplay between NETs and the immune system may provide new insights into the treatment of various inflammatory and autoimmune conditions.
In conclusion, neutrophil extracellular traps are dynamic structures that play a dual role in host defense and disease pathogenesis. Further research into the mechanisms underlying NET formation and function may lead to the development of targeted therapies for a range of immune-mediated disorders.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian